Try searching for...
Prof David Christie
MBChB, FRANZCR
For patients/carers
For doctors
MBChB, FRANZCR
Locations
- Ballina Day Surgery
- 46 Tamar Street, Ballina, NSW, 2478
- Availability: Alternate Fridays
Clinical interests
- Urological cancer
- Skin cancer
- Lymphoma
- Metastatic cancer
- Dupuytren's disease
- Ledderhose disease
- Osteoarthritis
- Keloid scars
- Soft tissue sarcoma
Treatment techniques
- External beam radiation therapy (EBRT)
- Volumetric modulated arc therapy (VMAT)
- Stereotactic radiotherapy (SBRT/SABR)
- Radiation therapy for benign conditions
- Palliative radiation therapy
- Hormone therapy
Languages
Fluent
- English
Biography
Clinical interests in urological (including prostate) cancers, and skin cancers plus benign conditions suitable for radiation therapy.
Professor David Christie is based on the Gold Coast and attends GenesisCare treatment centres at Tugun and Southport. He also attends clinics in Northern NSW (Ballina).
David qualified in Medicine from New Zealand’s University of Otago in 1987 and completed Radiation Oncology training in Sydney in 1995, at which time he moved to Queensland and commenced full-time practice. David has over 30 years’ experience in treating many cancer types that require radiation therapy.
He has research and teaching roles with the University of New England as well as Bond and Griffith Universities. Special clinical interests include urological cancer (including prostate SABR), skin cancer (including wide field radiotherapy), benign diseases (including dupuytren’s disease), lymphoma and patients eligible for clinical trials.
In addition to his clinical and academic roles, Professor Christie participates in multidisciplinary team (MDT) meetings across Northern NSW and the Gold Coast, working collaboratively with specialist colleagues to support comprehensive, coordinated patient care.
Consults at:
- Tugun
- Southport
- Ballina - Outreach clinic
More information
- Royal Australian and New Zealand College of Radiologists (RANZCR)
- Trans-Tasman Radiation Oncology Group (TROG)
- Bond University
- Griffith University
- University of New England
Professor Christie is an active contributor to several clinical trial organisations including TROG and has published over 200 publications.
Publications include:
- Christie, D.Preliminary efficacy and safety analysis: 12-month results in 83 patients using a novel approach of widefield radiation therapy for extensive skin field cancerization with or without keratinocyte cancersJournal of Dermatological Treatment33
- Christie, D. R. H., Sharpley, C. F., & Bitsika, V. (2025). A systematic review of the association between psychological resilience and improved psychosocial outcomes in prostate cancer patients: Could resilience training have a potential role? The World Journal of Men’s Health, 43(1), 70. https://doi.org/10.5534/wjmh.230319
- Sharpley, C. F., Arnold, W. M., Christie, D. R., & Bitsika, V. (2024). Network connectivity between psychological resilience and depression in prostate cancer patients. Psycho‐Oncology, 33(1), e6266.
